Zachary Warnken
Director, Pharmaceutical Development Via Therapeutics
Seminars
Thursday 4th February 2027
Selecting the Right Formulation Strategy For Intranasal Therapies: Balancing Performance, Risk & Manufacturability
11:00 am
- Develop a framework for selecting the most appropriate formulation approach based on molecule characteristics, target indication, and delivery objectives
- Understand the trade-offs between powders, liquids, nanoparticles, and enhanced formulations when balancing efficacy, manufacturability, stability, and patient experience
- Avoid costly reformulation and development delays by aligning formulation strategy with long-term clinical, regulatory, and commercial goals
